🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Currently, whether adjuvant therapy should be applied to Stage Ib non-small...
Status
Terminated
Location
West China Hospital
Start Date
2015-11-11
Trial ID
NCT02526537
ELIGIBILITY * Non-small cell lung cancer Clinical Stage 1A (T1N0M0 a tumor...
Status
Completed
Location
Toronto General Hospital
Start Date
2005-01
Trial ID
NCT00188617
Treatments Being Tested
This study is a single-arm,phase II study of gefitinib in patient with epid...
Status
Completed
Location
Samsung Medical Center
Start Date
2014-12-03
Trial ID
NCT02447419
Treatments Being Tested
This is a phase II trial to assess whether IRESSA™ (gefitinib) has anti-tum...
Status
Completed
Location
Multiple Locations
Start Date
2001-04
Trial ID
NCT00632723
Treatments Being Tested
1. Gefitinib CTTQ production gefitinib and erlotinib sheet AstraZeneca imat...
Status
Unknown
Location
Multiple Locations
Start Date
2017-08
Trial ID
NCT03264794
The purpose of this study is to compare the efficacy and safety of chemothe...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2007-02
Trial ID
NCT00409006
Treatments Being Tested
This study is being carried out to see if ZD1839 is effective in treating m...
Status
Completed
Location
Research Site
Start Date
2003-10
Trial ID
NCT00229697
Iressa \[epidermal growth factor tyrosine kinase inhibitor (EGFR-TKI)\] has...
Status
Completed
Location
Taipei VGH
Start Date
2005-11
Trial ID
NCT01037998
Treatments Being Tested
RATIONALE: Gefitinib may stop the growth of tumor cells by blocking the enz...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2004-01
Trial ID
NCT00086957
Treatments Being Tested
To assess the maximum tolerated dose and overall safety and tolerability of...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2004-10
Trial ID
NCT00113529
Treatments Being Tested